Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial
3/7 19:23
(RTTNews) - Clearmind Medicine Inc. (CMND), a clinical-stage biotech company developing psychedelic-derived treatments, has received Institutional Review Board or IRB approval from Tel Aviv Sourasky Medical Center or TASMC for its ongoing Phase 1/2a trial of CMND-100, an MEAI-bas...